| 摘要 |
The present invention is a method of screening a patient with macular edema associated with visual loss for implantation of a sustained release drug- delivery implant that is less invasive than implanting a drug-delivery impla nt and is minimally invasive. The method comprises injecting a first steroid, e g. triamcinolone acetonide, having anti-inflammatory activity as a bolus into a patient's eye. Patients that experience a reduction in swelling in the retin a (typically the macula and preferably the fovia) and improved vision are identified as candidate patients. Candidate patients are patients that are more likely to benefit from the implantation of a sustained release drug- delivery implant into the eye containing a second steroid, for example fluocinolone acetonide.
|
